Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-05-12
DOI
10.3389/fphar.2021.670155
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sodium-glucose cotransporter 2 inhibitors antagonize lipotoxicity in human myeloid angiogenic cells and ADP-dependent activation in human platelets: potential relevance to prevention of cardiovascular events
- (2020) Valentina Spigoni et al. Cardiovascular Diabetology
- The Vicious Circle of Left Ventricular Dysfunction and Diabetes: From Pathophysiology to Emerging Treatments
- (2020) Ilaria Cavallari et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The sodium-glucose cotransporter-2 (SGLT2) inhibitors synergize with nitric oxide and prostacyclin to reduce human platelet activation
- (2020) Caroline Honaiser Lescano et al. BIOCHEMICAL PHARMACOLOGY
- Linagliptin Regulates the Mitochondrial Respiratory Reserve to Alter Platelet Activation and Arterial Thrombosis
- (2020) Yi Li et al. Frontiers in Pharmacology
- Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA
- (2019) Darren K. McGuire et al. CIRCULATION
- Cardiovascular effects of SGLT-2 inhibitors: What we have learned from cardiovascular outcome trials and what we still need to understand
- (2019) Ilaria Cavallari et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
- (2019) Eri T. Kato et al. CIRCULATION
- Mechanisms of action of metformin with special reference to cardiovascular protection
- (2019) Alexey V. Zilov et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review
- (2019) Justyna Pordzik et al. Cardiovascular Diabetology
- Reconceptualization of the Molecular Mechanism by Which Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Heart Failure Events
- (2019) Milton Packer CIRCULATION
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2019) Francesco Cosentino et al. EUROPEAN HEART JOURNAL
- Hypercholesterolemia impairs the Glucagon-like peptide 1 action on platelets: Effects of a lipid-lowering treatment with simvastatin
- (2019) Cristina Barale et al. THROMBOSIS RESEARCH
- Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention
- (2019) Annunziata Nusca et al. Cardiovascular Diabetology
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2019) Søren L Kristensen et al. Lancet Diabetes & Endocrinology
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020
- (2019) DIABETES CARE
- The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)–TIMI 58 Trial
- (2018) Stephen D. Wiviott et al. AMERICAN HEART JOURNAL
- Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk
- (2018) Julio Rosenstock et al. Cardiovascular Diabetology
- Glycemic Variability in the Development of Cardiovascular Complications in Diabetes
- (2018) Annunziata Nusca et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes
- (2018) Sean L. Zheng et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- THE SGLT2 INHIBITOR EMPAGLIFLOZIN DOES NOT EXHIBIT PRO THROMBOTIC EFFECTS
- (2018) Carlos G. Santos-Gallego et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure
- (2018) John J.V. McMurray et al. JACC-Heart Failure
- Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury
- (2018) Annayya R. Aroor et al. Cardiovascular Diabetology
- Glucagon-like peptide-1 receptor action in the vasculature
- (2018) Malak Almutairi et al. PEPTIDES
- Use of Metformin and Platelet Reactivity in Diabetic Patients Treated with Dual Antiplatelet Therapy
- (2018) Monica Verdoia et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Sodium-glucose cotransporter inhibitors and oxidative stress: An update
- (2018) Habib Yaribeygi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study
- (2018) Peter Ueda et al. BMJ-British Medical Journal
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation
- (2017) Cristina Barale et al. THROMBOSIS AND HAEMOSTASIS
- Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
- (2017) Rury R Holman et al. Lancet Diabetes & Endocrinology
- The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
- (2017) Sebastian Steven et al. Redox Biology
- Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes
- (2016) Nisa M. Maruthur et al. ANNALS OF INTERNAL MEDICINE
- Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice
- (2016) Sebastian Steven et al. BRITISH JOURNAL OF PHARMACOLOGY
- Glucagon-Like Peptide 1 Receptor Activation Attenuates Platelet Aggregation and Thrombosis
- (2016) Alison Cameron-Vendrig et al. DIABETES
- Can a Shift in Fuel Energetics Explain the Beneficial Cardiorenal Outcomes in the EMPA-REG OUTCOME Study? A Unifying Hypothesis
- (2016) Sunder Mudaliar et al. DIABETES CARE
- Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME®trial
- (2016) David Fitchett et al. EUROPEAN HEART JOURNAL
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meal-induced platelet activation in diabetes mellitus type 1 or type 2 is related to postprandial insulin rather than glucose levels
- (2016) Galia Spectre et al. THROMBOSIS RESEARCH
- The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials
- (2016) Dimitris Varvaki Rados et al. PLOS MEDICINE
- Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor
- (2016) Annarita Carino et al. Biomed Research International
- Metformin Uniquely Prevents Thrombosis by Inhibiting Platelet Activation and mtDNA Release
- (2016) Guang Xin et al. Scientific Reports
- Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and DeathCLINICAL PERSPECTIVE
- (2015) Matthew A. Cavender et al. CIRCULATION
- Effects of Acute and Antecedent Hypoglycemia on Endothelial Function and Markers of Atherothrombotic Balance in Healthy Humans
- (2015) Nino G. Joy et al. DIABETES
- Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®)
- (2015) Nikolaus Marx et al. Diabetes & Vascular Disease Research
- Cardiovascular and heart failure safety profile of vildagliptin: a meta-analysis of 17 000 patients
- (2015) G. McInnes et al. DIABETES OBESITY & METABOLISM
- Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes
- (2015) R. Chilton et al. DIABETES OBESITY & METABOLISM
- Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-term Mortality
- (2015) Trevor J. Orchard et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Excess Mortality among Persons with Type 2 Diabetes
- (2015) Mauro Tancredi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Jennifer B. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls
- (2015) Hassan Kahal et al. BMC Endocrine Disorders
- Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial
- (2015) Jacob A. Udell et al. DIABETES CARE
- Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: Rationale and design of the Insulin Resistance Intervention after Stroke Trial
- (2014) Catherine M. Viscoli et al. AMERICAN HEART JOURNAL
- Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
- (2014) Erin E. Mulvihill et al. ENDOCRINE REVIEWS
- Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease
- (2014) Dominick J. Angiolillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Different Degrees of NADPH Oxidase 2 Regulation and In Vivo Platelet Activation: Lesson From Chronic Granulomatous Disease
- (2014) Roberto Carnevale et al. Journal of the American Heart Association
- Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients: a preliminary report
- (2013) Miao-yan Zheng et al. Cardiovascular Diabetology
- Acetylsalicylic acid therapy: Influence of metformin use and other variables on urinary 11-dehydrothromboxane B2 levels
- (2013) Lillian Harboe Gonçalves et al. CLINICA CHIMICA ACTA
- The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus
- (2013) Hanford Yau et al. Current Diabetes Reports
- The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview
- (2013) David M. Nathan et al. DIABETES CARE
- Glucagon-Like Peptide 1 Reduces Endothelial Dysfunction, Inflammation, and Oxidative Stress Induced by Both Hyperglycemia and Hypoglycemia in Type 1 Diabetes
- (2013) A. Ceriello et al. DIABETES CARE
- Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials
- (2013) M. Monami et al. DIABETES OBESITY & METABOLISM
- Cardiovascular effects of gliptins
- (2013) André J. Scheen Nature Reviews Cardiology
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Postprandial Platelet Activation Is Related to Postprandial Plasma Insulin Rather Than Glucose in Patients With Type 2 Diabetes
- (2012) G. Spectre et al. DIABETES
- Platelet Isoprostane Overproduction in Diabetic Patients Treated With Aspirin
- (2012) R. Cangemi et al. DIABETES
- Cardiovascular Biology of the Incretin System
- (2012) John R. Ussher et al. ENDOCRINE REVIEWS
- Vildagliptin inhibits oxidative stress and vascular damage in streptozotocin-induced diabetic rats
- (2012) Sayaka Maeda et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- A Dipeptidyl Peptidase-4 Inhibitor, Des-Fluoro-Sitagliptin, Improves Endothelial Function and Reduces Atherosclerotic Lesion Formation in Apolipoprotein E–Deficient Mice
- (2012) Junichi Matsubara et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- The effect of metformin on mean platelet volume in dıabetıc patients
- (2012) Ilhan Dolasık et al. PLATELETS
- Sitagliptin: Anti-platelet effect in diabetes and healthy volunteers
- (2012) Ashish Kumar Gupta et al. PLATELETS
- Effects of pioglitazone on platelet P2Y12-mediated signalling in clopidogrel-treated patients with type 2 diabetes mellitus
- (2012) S. Suryadevara et al. THROMBOSIS AND HAEMOSTASIS
- Pioglitazone inhibits platelet function and potentiates the effects of aspirin: A prospective observation study
- (2012) John Mongan et al. THROMBOSIS RESEARCH
- Loss of DPP4 activity is related to a prothrombogenic status of endothelial cells: implications for the coronary microvasculature of myocardial infarction patients
- (2011) Paul A. J. Krijnen et al. BASIC RESEARCH IN CARDIOLOGY
- Optimizing Platelet Inhibition in Clopidogrel Poor Metabolizers
- (2011) Dominick J. Angiolillo et al. JACC-Cardiovascular Interventions
- Effect of Enhanced Glycemic Control with Saxagliptin on Endothelial Nitric Oxide Release and CD40 Levels in Obese Rats
- (2011) R. Preston Mason et al. Journal of Atherosclerosis and Thrombosis
- Impact of Platelet Reactivity on Clinical Outcomes After Percutaneous Coronary Intervention
- (2011) Somjot S. Brar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
- (2011) Ralph A. DeFronzo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glucagon-Like Peptide 1 Prevents Reactive Oxygen Species–Induced Endothelial Cell Senescence Through the Activation of Protein Kinase A
- (2010) Hisko Oeseburg et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effect of Pioglitazone on Platelet Aggregation in a Healthy Cohort
- (2010) Warangkana Chokesuwattanaskul et al. CARDIOLOGY
- Hyperglycemia-Induced Platelet Activation in Type 2 Diabetes Is Resistant to Aspirin but Not to a Nitric Oxide-Donating Agent
- (2010) P. Gresele et al. DIABETES CARE
- Effects of Acute Hypoglycemia on Inflammatory and Pro-atherothrombotic Biomarkers in Individuals With Type 1 Diabetes and Healthy Individuals
- (2010) N. Gogitidze Joy et al. DIABETES CARE
- Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials
- (2010) C. Lamanna et al. DIABETES OBESITY & METABOLISM
- Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
- (2010) Stefan James et al. EUROPEAN HEART JOURNAL
- Glybenclamide: An antidiabetic with in vivo antithrombotic activity
- (2010) Harold J. Ting et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus
- (2010) F. SANTILLI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitus
- (2010) Hiroyuki Konya et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Sulfonylureas and on-clopidogrel platelet reactivity in type 2 diabetes mellitus patients
- (2010) Ankie M. Harmsze et al. PLATELETS
- Vascular actions of insulin with implications for endothelial dysfunction
- (2009) Maria Assunta Potenza et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes Mellitus
- (2009) Adriaan Kooy et al. ARCHIVES OF INTERNAL MEDICINE
- Effect of acarbose on platelet-derived microparticles, soluble selectins, and adiponectin in diabetic patients
- (2009) Takayuki Shimazu et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- A shear gradient–dependent platelet aggregation mechanism drives thrombus formation
- (2009) Warwick S Nesbitt et al. NATURE MEDICINE
- Cardiovascular Outcomes in Trials of Oral Diabetes Medications
- (2008) Elizabeth Selvin et al. ARCHIVES OF INTERNAL MEDICINE
- Effect of Acarbose on Vascular Disease in Patients with Abnormal Glucose Tolerance
- (2008) Markolf Hanefeld et al. CARDIOVASCULAR DRUGS AND THERAPY
- Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38
- (2008) Stephen D. Wiviott et al. CIRCULATION
- Is the Combination of Sulfonylureas and Metformin Associated With an Increased Risk of Cardiovascular Disease or All-Cause Mortality?: A meta-analysis of observational studies
- (2008) A. D. Rao et al. DIABETES CARE
- Point-of-Care Measurement of Clopidogrel Responsiveness Predicts Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention
- (2008) Giuseppe Patti et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Decreasedin vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects
- (2007) Gloria Formoso et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now